MAPT and Alzheimer disease: The aim of this study was to examine the association of previously implicated genetic markers in and near IL1RAP in relation to AD risk, CSF tau and Aβ biomarkers, as well as cognitive decline over time, in a case (AD)-control study and an age homogenous representative population-based cohort.